Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes (Q42999133)

From Wikidata
Jump to navigation Jump to search
scientific article published in August 2010
edit
Language Label Description Also known as
English
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
scientific article published in August 2010

    Statements

    Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes (English)
    1 August 2010
    716-721

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit